bpc 157 subq or im BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA BPC-157 Dosage Calculator: Units, mL
Description
This means their safety and effectiveness cannot be confirmed
This approach mirrors dosing strategies used for other peptides with 1216 hour half-lives, though published 5-amino-1mq pharmacokinetic data in humans remains limited
What is Juvederm
Standard Knee Protocol Dosage: 250-500 mcg per day, injected subcutaneously near the knee
